Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > News > BioSante Pharmaceuticals Announces Positive Results

April 29th, 2004

BioSante Pharmaceuticals Announces Positive Results

Abstract:
BioSante Pharmaceuticals, Inc. today announced that a comparative preclinical study demonstrated its calcium phosphate nanotechnology-based vaccine adjuvant, BioVant(TM), may be more effective than aluminum salt derivatives, the only adjuvant currently approved by the Food and Drug Administration. The study was conducted in collaboration with the U.S. Centers for Disease Control and Prevention in a previously unannounced BioSante collaboration.

Source:
Businesswire

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Nanoparticle vaccine shows potential as immunotherapy to fight multiple cancer types April 24th, 2017

Arrowhead Presents ARC-520 and ARC-521 Clinical Data at The International Liver Congress(TM) April 20th, 2017

Nano-SPEARs gently measure electrical signals in small animals: Rice University's tiny needles simplify data gathering to probe diseases, test drugs April 17th, 2017

Nanotubes that build themselves April 14th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project